Renub

    Point of Care Testing Market, Global Forecast, by Diagnostics, Mode, End Users, Regions & Companies

    Excel: 4 Hours
    PDF: 4 Hours
    May 2018
    Pages: 132

    Get Free Customization in This Report

    Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.

    Point of Care Testing market is expected to witness substantial growth due to rising incidence of chronic diseases; rapidly growing middle class population in developing countries like China & India, Continued Expansion of Point of Care Including Self Testing and New Evolution in Point of Care Testing further boosts the demand for the industry over the forecast period. 

     

    Request a free sample copy of the report: https://www.renub.com/contactus.php  


    Renub Research report titled “Point of Care Testing Market, Global Forecast, By Diagnostics (Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker), Mode (Prescription-based Testing and OTC-based Testing), End Users (Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home), Regions (North America, Europe, Asia-Pacific Latin America and Middle East/Africa), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic Becton, Dickinson & Company and Johnson & Johnson)” provides a complete analysis of Point of Care Testing Market. 


    By Diagnostics - Blood Glucose and Infectious Disease controls the Point of Care Testing Market

    The report studies the market of the following Diagnostics segments: Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker. 


    By Mode – OTC-based Testing has Intense Future Ahead

    The report studies the Point of Care Diagnostics market by Prescription-based Testing and OTC-based Testing.


    By End Users – Hospital and Clinic Point of Care Testing Market have Bright Future

    It is believed that in near future; Hospital Point of Care Testing Market will certainly rule the Point of Care Testing Market. The report provides a detailed competitive landscaping Market of Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home.

    point-of-care-testing-market-and-forecast-(2018-2024)


    By Region – North America and Europe will drive the Point of Care Testing Market
     
    North America and Europe together controls the Point of Care Testing Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific Latin America and Middle East/Africa Point of Care Testing Market.


    Companies Analysis

    Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic, Becton, Dickinson & Company and Johnson & Johnson are some of the top companies operating in the Point of Care Testing; which has been studied thoroughly in the report.


    All the 6 Companies Studied in the Report have been Studied from 3 Points 

    •    Company Overview    
    •    Business Portfolio
    •    Financial Insight

    This market research report provides a complete analysis of the Point of Care Testing Market, Growth Drivers, Challenges, and their projections for the upcoming years.   

     

    Client can purchase this report in sections through Purchase by Chapter Tab given above


    By Testing Segments

    •    Blood Glucose 
    •    Cardiac Marker 
    •    Lipid Panel/Cholesterol 
    •    Blood Coagulation 
    •    Infectious Disease
    •    Urinalysis
    •    Drug of Abuse
    •    Fecal Occult Blood
    •    Pregnancy & Fertility
    •    Tumor Marker


    By Mode 

    •    Prescription-based Testing
    •    OTC-based Testing


    By End Users 

    •    Hospital
    •    Clinic
    •    Laboratories
    •    Assisted Living Healthcare Facilities
    •    Home


    By Region

    •    North America
    •    Europe
    •    Asia-Pacific
    •    Latin America
    •    Middle East/Africa


    Key Companies Covered in the Report:

    •    Abbott Laboratories
    •    Siemens Healthineers
    •    Roche Diagnostics
    •    Quest Diagnostic
    •    Becton, Dickinson and Company
    •    Johnson & Johnson

    1.    Executive Summary

    2.    Global Point of Care Testing Market & Forecast

    3.    Market Share – Global Point of Care Testing

    3.1    By Diagnostics

    3.2    By Region

    4.    Diagnostics Segments – Point of Care Market (2010 – 2024)

    4.1    Blood Glucose Testing Market

    4.2    Cardiac Marker Testing Market

    4.3    Lipid Panel/Cholesterol Testing Market

    4.4    Blood Coagulation Testing Market

    4.5    Infectious Disease Testing Market

    4.6    Urinalysis Testing Market

    4.7    Drug of Abuse Testing Market

    4.8    Fecal Occult Blood Testing Market

    4.9    Pregnancy & Fertility Testing Market

    4.10    Tumor Marker Testing Market

    5.    By Mode - Global Point of Care Testing Market (2010 – 2024)

    5.1    Prescription-based Testing

    5.2    OTC-based Testing

    6.    By End User - Global Point of Care Testing Market & Forecast

    6.1    Hospital

    6.2    Clinic

    6.3    Laboratories

    6.4    Assisted Living Healthcare Facilities

    6.5    Home

    7.    By Region - Global Point of Care Testing Market & Forecast

    7.1    North America

    7.2    Europe

    7.3    Asia-Pacific

    7.4    Latin America

    7.5    Middle East/Africa (MEA)

    8.    Abbott Laboratories – Company Analysis

    8.1    Overview

    8.2    Business Portfolio

    8.2.1    Point A
    8.2.2    Point B
    8.2.3    Point C
    8.2.4    Point D

    8.3    Financial Insight

    9.    Siemens Healthineers – Company Analysis

    9.1    Overview

    9.2    Business Portfolio

    9.2.1    Point A
    9.2.2    Point B
    9.2.3    Point C

    9.3    Financial Insight

    10.    Roche Diagnostics – Company Analysis

    10.1    Overview

    10.2    Business Portfolio

    10.2.1    Point A
    10.2.2    Point B
    10.2.3    Point C

    10.3    Financial Insight

    11.    Quest Diagnostic – Company Analysis

    11.1    Overview

    11.2    Business Portfolio

    11.2.1    Point A
    11.2.2    Point B
    11.2.3    Point C
    11.2.4    Point D

    11.3    Financial Insight

    12.    Becton, Dickinson and Company – Company Analysis

    12.1    Overview

    12.2    Business Portfolio

    12.2.1    Point A
    12.2.2    Point B
    12.2.3    Point C
    12.2.4    Point D

    12.3    Financial Insight

    13.    Johnson & Johnson – Company Analysis

    13.1    Overview

    13.2    Business Strategy

    13.2.1    Point A
    13.2.2    Point B
    13.2.3    Point C

    13.3    Financial Insight

    14.    Growth Drivers

    14.1    Rise in Chronic Diseases Driving Demand

    14.2    Continued Expansion of Point of Care Including Self Testing

    14.2.1    The Promise of Point-of-Care Testing
    14.2.2    Future of Point of Care Testing – The ‘Worried Well’
    14.2.3    Theranostics – Companion Diagnostics
    14.2.4    Hub and Spoke
    14.2.5    Education

    14.3    New Evolution Enhances Point of Care Testing Market

    14.3.1    Point of Care Testing (POCT)
    14.3.2    On the Market
    14.3.3    Expanding Test Menu
    14.3.4    Diabetes Tests
    14.3.5    Chronic Kidney Disease
    14.3.6    Oral Specimens

    14.4    Point of Care Testing: A Step to the Future

    14.4.1    Paradigm Shifts
    14.4.2    Why Consider POCT?
    14.4.3    Benefit of Point of Care Testing
    14.4.4    The Future

    15.    Challenges

    15.1    Manufacturing Obstacles in POC Testing Product Development

    15.1.1    Avoiding Too Much, Too Soon
    15.1.2    Closely Considering Materials and Environment

    15.2    Point of Care (POC) Testing Barriers in Low & Middle Income Countries

    15.2.1    Barriers to Adoption & Scale-up of POC Technologies
    15.2.2    Technical, Administrative & Operational Barriers of Point of Care Tests
    15.2.3    Health System Related Barriers of Point of Care Tests
    15.2.4    Economic Barriers of Point of Care Tests

     

    List of Figures

    Figure 2‑1: Global – Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 2‑2: Global – Forecast for Point of Care Testing Market (Billion US$), 2018 – 2024

    Figure 3‑1: By Testing – Point of Care Testing Market Share (%), 2010 – 2017
    Figure 3‑2: By Testing – Forecast for Point of Care Testing Market Share (%), 2018 – 2024
    Figure 3‑3: By Region – Point of Care Testing Market Share (%), 2010 – 2017
    Figure 3‑4: By Region – Forecast for Point of Care Testing Market Share (%), 2018 – 2024

    Figure 4‑1: Global – Blood Glucose Testing Market (Million US$), 2010– 2017
    Figure 4‑2: Global – Forecast for Blood Glucose Testing Market (Million US$), 2018 – 2024
    Figure 4‑3: Global – Cardiac Marker Testing Market (Million US$), 2010 – 2017
    Figure 4‑4: Global – Forecast for Cardiac Marker Testing Market (Million US$), 2018 – 2024
    Figure 4‑5: Global – Lipid Panel/Cholesterol Testing Market (Million US$), 2010 – 2017
    Figure 4‑6: Global – Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2018 – 2024
    Figure 4‑7: Global – Blood Coagulation Market (Million US$), 2010 - 2017
    Figure 4‑8: Global – Forecast for Blood Coagulation Market (Million US$), 2018 – 2024
    Figure 4‑9: Global – Infectious Disease Testing Market (Million US$), 2010 – 2017
    Figure 4‑10: Global – Forecast for Infectious Disease Testing Market (Million US$), 2018 – 2024
    Figure 4‑11: Global – Urinalysis Testing Market (Million US$), 2010 – 2017
    Figure 4‑12: Global – Forecast for Urinalysis Testing Market (Million US$), 2018 – 2024
    Figure 4‑13: Global – Drug of Abuse Testing Market (Million US$), 2010 – 2017
    Figure 4‑14: Global – Forecast for Drug of Abuse Testing Market (Million US$), 2018 – 2024
    Figure 4‑15: Global – Fecal Occult Blood Testing Market (Million US$), 2010 – 2017
    Figure 4‑16: Global – Forecast for Fecal Occult Blood Testing Market (Million US$), 2018 – 2024
    Figure 4‑17: Global – Pregnancy & Fertility Testing Market (Million US$), 2010 – 2017
    Figure 4‑18: Global – Forecast for Pregnancy & Fertility Testing Market (Million US$), 2018 – 2024
    Figure 4‑19: Global – Tumor Marker Testing Market (Million US$), 2010 – 2017
    Figure 4‑20: Global – Forecast for Tumor Marker Testing Market (Million US$), 2018 – 2024

    Figure 5‑1: Prescription-based Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 5‑2: Forecast for Prescription-based Point of Care Testing Market (Billion US$), 2018 – 2024
    Figure 5‑3: OTC-based Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 5‑4: Forecast for OTC-based Point of Care Testing Market (Billion US$), 2018 – 2024

    Figure 6‑1: Hospital - Point of Care Testing Market (Billion US$), 2010 - 2017
    Figure 6‑2: Forecast for Hospital - Point of Care Testing Market (Billion US$), 2018 - 2024
    Figure 6‑3: Clinic - Point of Care Testing Market (Billion US$), 2010 - 2017
    Figure 6‑4: Forecast for Clinic - Point of Care Testing Market (Billion US$), 2018 - 2024
    Figure 6‑5: Laboratories - Point of Care Testing Market (Billion US$), 2010 - 2017
    Figure 6‑6: Forecast for Laboratories - Point of Care Testing Market (Billion US$), 2018 - 2024
    Figure 6‑7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Billion US$), 2010 - 2017
    Figure 6‑8: Forecast for Assisted Living Healthcare Facilities - Point of Care Testing Market (Billion US$), 2018 - 2024
    Figure 6‑9: Home - Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 6‑10: Forecast for Home - Point of Care Testing Market (Billion US$), 2018 - 2024

    Figure 7‑1: North America - Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 7‑2: Forecast for North America - Point of Care Testing Market (Billion US$), 2018 – 2024
    Figure 7‑3: Europe - Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 7‑4: Forecast for Europe - Point of Care Testing Market (Billion US$), 2018 – 2024
    Figure 7‑5: Asia Pacific - Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 7‑6: Forecast for Asia Pacific - Point of Care Testing Market (Billion US$), 2018 – 2024
    Figure 7‑7: Latin America - Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 7‑8: Forecast for Latin America - Point of Care Testing Market (Billion US$), 2018 – 2024
    Figure 7‑9: Middle East/Africa - Point of Care Testing Market (Billion US$), 2010 – 2017
    Figure 7‑10: Forecast for Middle East/Africa - Point of Care Testing Market (Billion US$), 2018 – 2024

    Figure 8‑1: Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2011 – 2017
    Figure 8‑2: Forecast for Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2018 – 2024

    Figure 9‑1: Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2011 – 2017
    Figure 9‑2: Forecast for Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2018 – 2024

    Figure 10‑1: Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2011 – 2017
    Figure 10‑2: Forecast for Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2018 – 2024

    Figure 11‑1: Quest Diagnostic Net Sales (Million US$), 2011 – 2017
    Figure 11‑2: Forecast for Quest Diagnostic Net Sales (Million US$), 2018 – 2024

    Figure 12‑1: Becton, Dickinson and Company Net Sales (Million US$), 2010 – 2017
    Figure 12‑2: Forecast for Becton, Dickinson and Company Net Sales (Million US$), 2018 – 2024

    Figure 13‑1: Johnson & Johnson (DePuy Synthes) Net Sales (Billion US$), 2011 - 2017
    Figure 13‑2: Forecast for Johnson & Johnson (DePuy Synthes) Net Sales (Billion US$), 2018 - 2024

    Figure 14‑1: Global Health Observatory data Total death by diseases (Million) 2015

     

    List of Tables 

    Table 15-1: Barriers to Adoption & Scale-up of POC Technologies
    Table 15-2: Technical, Administrative & Operational Barriers of POC Tests in Low & Middle-Income Countries
    Table 15-3: Health System Related Barriers of POC Tests in Low & Middle-Income Countries
    Table 15-4: Economic Barriers of POC Tests in Low & Middle Income Country

    • Description
      Price
    • Chapter 1 & 2     Pages : 20
      $700
    • Chapter 3     Pages : 5
      $600
    • Chapter 4     Pages : 23
      $700
    • Chapter 5     Pages : 4
      $500
    • Chapter 6     Pages : 10
      $600
    • Chapter 7     Pages : 10
      $600
    • Chapter 8     Pages : 6
      $300
    • Chapter 9     Pages : 5
      $300
    • Chapter 10     Pages : 5
      $300
    • Chapter 11     Pages : 5
      $300
    • Chapter 12     Pages : 5
      $300
    • Chapter 13     Pages : 6
      $300
    • Chapter 14     Pages : 14
      $300
    • Chapter 15     Pages : 11
      $300

    Related Reports